MedTrace Logo

Impact of COVID-19 Pandemic on Single-stage Laparoscopic Cholecystectomy and Laparoscopic Common Bile Duct Exploration Service

NCT06974045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237

Last updated 2026-03-27

No results posted yet for this study

Summary

Choledocholithiasis is reported to be present in 15-20% of patients with symptomatic gallstones. The single-stage management consists of performing either laparoscopic common bile duct exploration (LCBDE) or intraoperative endoscopic retrograde cholangiopancreatography (ERCP) at the same time as laparoscopic cholecystectomy (LC).

Since the Coronavirus (COVID-19) pandemic, surgical practice has significantly been impacted. The pandemic has had ramifications on patient and staff safety, surgical techniques, minimally invasive procedures, theatre workflow, education and training.

The investigators analysed a series of LCBDE procedures in our institution pre-, intra- and post-COVID-19 pandemic to assess the feasibility, efficacy and safety of this single-stage treatment approach following the pandemic.

Conditions

  • Gallstone

Interventions

OTHER

Single-stage LC + LCBDE

Choledochotomy and transductal common bile duct exploration or transcystic choledochoscopy and common bile duct exploration

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-01
Primary Completion
2024-02-01
Completion
2025-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06974045 on ClinicalTrials.gov